Professional Education
Shoulder Dystocia Clinician-Patient Disclosure
This enduring activity is designed to assist physicians and advanced practice clinicians (APCs) in enhancing their communication skills when disclosing a shoulder dystocia injury to patients and family members. This type of injury to the infant may, unfortunately, occur despite the best of care; however, effective physician-patient communication is an integral part of clinical practice and has been shown to positively influence outcomes by increasing patient understanding and trust.
Search
Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From
The Doctor’s Advocate
Billions for Defense: The Pervasive Nature of Defensive Medicine
Physicians practice defensive medicine all the time—some acknowledge and accept it, while others believe it is untrue and unconscionable. The Doctors Company CEO and Chairman Richard E. Anderson, MD, FACP, examines the pervasive nature of defensive medicine in this article.
May 20, 2024, Part B News
CMS: In AWV, SDOH Assessment Can Occur Days Before Visit; Append Modifier
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses a Change Request pertaining to the use of social determinants of health (SDOH) risk assessments during Medicare annual wellness visits (AWV).
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
What Do People Actually Want from Primary Care?
Ami Parekh, MD, JD, Chief Health Officer, Included Health, and Member, Board of Governors, The Doctors Company, Part of TDC Group, presents at the 2025 TDC Group Executive Advisory Board Meeting about the current and future state of primary care in the U.S.
The Doctors Company Commits to Health Workforce Well-Being as a Founding Member of the National Academy of Medicine’s Change Maker Campaign
On the 1st anniversary of the National Plan for Health Workforce Well-Being, The Doctors Company reinforces its commitment to health workforce well-being as a founding member of the Change Maker campaign of the National Academy of Medicine (NAM). The national plan provides a roadmap for collective action to address the health worker burnout crisis, strengthen workplace well-being, and restore the nation’s health.
Plastic Surgery Closed Claims Study Reveals Most Common Case Types
In this study of plastic surgery closed claims, The Doctors Company looks at the most common case types, most common patient injuries, primary drivers / frequent allegations, and strategies for mitigating risk for both cosmetic and reconstructive surgery.
Jun 05, 2025
The Doctors Company Announces Acquisition of ProAssurance
The Doctors Company has entered into a definitive agreement to acquire ProAssurance, and other company news and insights.
From
The Doctor’s Advocate
The Doctors Company Receives Datos Insights 2025 Impact Award for Insurance Innovation
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
